Vascular brachytherapy firm Novoste of Norcross, GA, has selected Alfred Novak as its president and chief executive officer. Novak assumed his duties yesterday, replacing William Hawkins. The company's current chairman and CEO, Thomas Weldon, will remain as chairman of the board of directors.
By AuntMinnie.com staff writersOctober 17, 2002
Related Reading
In-stent restenosis brachytherapy benefits from longer radiation sources, March 18, 2002
Radiation proves robust for preventing in-stent restenosis, September 10, 2001
Gamma radiation reduces in-stent restenosis rate in saphenous vein grafts, March 20, 2001
FDA likely to approve new brachytherapy for coronary artery restenosis, September 26, 2000
Copyright © 2002 AuntMinnie.com